摘要
阿尔茨海默氏病(AD)是全世界痴呆的最常见形式。 2型糖尿病(T2D)已经成为AD的一个危险因素。因为T2D是外围炎性病症,且AD脑中显示出恶化神经炎症,我们推测炎症机制可能导致了T2D和AD之间的已观察到的相关性。异常外周和脑胰岛素浓度在T2D和AD中都被报道过。胰岛素的神经营养作用已被描述然而,这种激素也能调节周边部的炎症反应。因此,我们在体外使用人细胞培养系统来阐明胰岛素对神经炎症的可能影响。我们证明,人类星形细胞和小胶质细胞表达胰岛素受体的两种异构体,以及胰岛素样生长因子(IGF)-1受体。它们还表达胰岛素受体底物(IRS)-1和IRS-2,这都需要的胰岛素/ IGF-1信号传播。我们表明,在低纳摩尔浓度下,胰岛素可以过通过刺激的人小胶质细胞分泌(IL)-6和IL-8、刺激的人星形胶质细胞分泌IL-8,上调白细胞介素发挥促炎症作用。这种效应在较高的胰岛素浓度下消失。相比之下,胰岛素在更宽的浓度范围(10pM - 1μM)减少刺激的人小胶质细胞和THP-1单核细胞对SH-SY5Y神经元细胞的毒性。这些数据表明,胰岛素可以通过调节神经胶质细胞的选择功能,影响神经元促进观察到的T2D和AD之间链路产生,调节其炎症状态。
关键词: 阿尔茨海默氏症、星形胶质细胞、细胞因子、IGF-1,小神经胶质细胞、神经衰弱、神经毒性、2型糖尿病。
Current Alzheimer Research
Title:Insulin Modulates In Vitro Secretion of Cytokines and Cytotoxins by Human Glial Cells
Volume: 12 Issue: 7
Author(s): Lindsay J. Spielman, Manpreet Bahniwal, Jonathan P. Little, Douglas G. Walker and Andis Klegeris
Affiliation:
关键词: 阿尔茨海默氏症、星形胶质细胞、细胞因子、IGF-1,小神经胶质细胞、神经衰弱、神经毒性、2型糖尿病。
摘要: Alzheimer’s disease (AD) is the most common form of dementia worldwide. Type 2 diabetes (T2D) has been implicated as a risk factor for AD. Since T2D is a peripheral inflammatory condition, and AD brains exhibit exacerbated neuroinflammation, we hypothesized that inflammatory mechanisms could contribute to the observed link between T2D and AD. Abnormal peripheral and brain insulin concentrations have been reported in both T2D and AD. The neurotrophic role of insulin has been described; however, this hormone can also regulate inflammatory responses in the periphery. Therefore we used in vitro human cell culture systems to elucidate the possible effects of insulin on neuroinflammation. We show that human astrocytes and microglia express both isoforms of the insulin receptor as well as the insulin-like growth factor (IGF)-1 receptor. They also express insulin receptor substrate (IRS)-1 and IRS-2, which are required for propagation of insulin/IGF- 1 signaling. We show that at low nanomolar concentrations, insulin could be pro-inflammatory by upregulating secretion of interleukin (IL)-6 and IL-8 from stimulated human astrocytes and secretion of IL-8 from stimulated human microglia. This effect dissipates at higher insulin concentrations. In contrast, insulin at a broader concentration range (10 pM – 1 μM) reduces the toxicity of stimulated human microglia and THP-1 monocytic cells towards SH-SY5Y neuronal cells. These data show that insulin may regulate the inflammatory status of glial cells by modulating their select functions, which in turn can influence the survival of neurons contributing to the observed link between T2D and AD.
Export Options
About this article
Cite this article as:
Lindsay J. Spielman, Manpreet Bahniwal, Jonathan P. Little, Douglas G. Walker and Andis Klegeris , Insulin Modulates In Vitro Secretion of Cytokines and Cytotoxins by Human Glial Cells, Current Alzheimer Research 2015; 12 (7) . https://dx.doi.org/10.2174/1567205012666150710104428
DOI https://dx.doi.org/10.2174/1567205012666150710104428 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
Current Neuropharmacology Neuronal and Vascular Oxidative Stress in Alzheimers Disease
Current Neuropharmacology The Cell Cycle and Hormonal Fluxes in Alzheimer Disease: A Novel Therapeutic Target
Current Pharmaceutical Design BRI2 Interacts with BACE1 and Regulates Its Cellular Levels by Promoting its Degradation and Reducing Its mRNA Levels
Current Alzheimer Research Flavones from Root of Scutellaria Baicalensis Georgi: Drugs of the Future in Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Functional Selectivity in Cannabinoid Signaling
Current Molecular Pharmacology Multidrug-Resistance (MDR) Proteins Develops Refractory Epilepsy Phenotype:Clinical and Experimental Evidences
Current Drug Therapy Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Current Pharmaceutical Design Oxidative Mediated Neurodegeneration in Alzheimers Disease: Melatonin and Related Indoles as Neuroprotective Agents
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Characterization of LC-HCC Fusion Protein of Botulinum Neurotoxin Type A
Protein & Peptide Letters Regulation of Cell Death and Survival by Resveratrol: Implications for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry CDK9: Therapeutic Perspective in HCC Therapy
Current Cancer Drug Targets Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics
Current Molecular Pharmacology Targeted Tumor Diagnosis and Therapy with Peptide Hormones as Radiopharmaceuticals
Anti-Cancer Agents in Medicinal Chemistry Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: A Systematic Review
Current Neuropharmacology Pyridinium Oxime Reactivators of Cholinesterase Inhibited by Diisopropyl- Fluorophosphate (DFP): Predictive Value of In-Vitro Testing for In-Vivo Efficacy
Mini-Reviews in Medicinal Chemistry Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells
Current Pharmaceutical Biotechnology Antibody-Targeted Immunoliposomes for Cancer Treatment
Mini-Reviews in Medicinal Chemistry Transcriptionally Targeted Adenovirus Vectors
Current Gene Therapy Anti-cancer and Anti-angiogenic Properties of Various Natural Pentacyclic Tri-terpenoids and Some of their Chemical Derivatives
Current Organic Chemistry